Deadline
Passed
Lead Plaintiff Deadline: June 02, 2020
Please Upload related files below
Fill in below.
Looking for more?
08
Feb 2019
13
Dec 2019
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose: (1) the reasons for Gossamer’s GB001 trial failures; (2) the purported clinical validation of Novartis’ oral DP2 antagonist; and (3) that, as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of Gossamer, either: A) purchased or acquired during the class period listed above, if applicable; or B) pursuant to the Initial Public Offering (IPO) of Gossamer, if applicable.
If you suffered a loss in Gossamer during the relevant time frame, or pursuant to Gossamer’s IPO if listed above, you have until June 02, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.